Precision Neuroscience

[PRIVATE]

Service & Cobot Robotics · HQ: New York, New York · Est. 2021 · 1 model registered · 2 deployments

New deployment

As of Sep 2026, DEPLOY verifies Precision Neuroscience: 1 model, 2 deployments across 2 regions, $120.0M raised. 2 sources back the record.

Ownership

PRIVATE

Capital / Funding

$120.0M

Headquarters

New York, New York

IP / Patents

Undisclosed

Platform Models

1

Audited Incidents

0

Overview

Precision Neuroscience is a New York-based brain-computer interface company developing the Layer 7 Cortical Interface, a minimally invasive, safely removable BCI with 1,024 electrodes on a thin flexible film. FDA 510(k) clearance granted April 2025 — first full regulatory clearance for a next-generation wireless BCI. Tested in 37 patients across Mount Sinai, Penn Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel. Raised $161M total (Series B $41M, Series C $120M).

Audited Posture AssessmentPeer Percentile: 77.8%

Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.

Key Facts

HeadquartersNew York, New York, USA
Founded2021
Statusprivate
Typehardware

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for Precision Neuroscience.

Leadership & Founders

3 entries

Current Program Leadership & Executives

Michael Magersecondary-verified

CEO & Co-Founder

Dr. Benjamin Rapoportsecondary-verified

Co-Founder & Chief Science Officer

Founding Team

Dr. Benjamin Rapoport[Founder]

cofounder · Neuralink

Partnerships & Commercial Deployments

2 entries
Total Tracked0
Operating0
Announced0
Concluded0

Operator Customers & Fleet Integrators

Precision Neuroscience - 2 deploymentsPrecision Neuroscience

Platform Models

1 entry

Deployments

2 entries

Sectors & Applications

1 entry

FAQ

14 entries
What is Precision Neuroscience?

Precision Neuroscience is a New York-based brain-computer interface company developing the Layer 7 Cortical Interface, a minimally invasive, safely removable BCI with 1,024 electrodes on a thin flexible film. FDA 510(k) clearance granted April 2025 — first full regulatory clearance for a next-generation wireless BCI. Tested in 37 patients across Mount Sinai, Penn Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel. Raised $161M total (Series B $41M, Series C $120M).

What does Precision Neuroscience make?

Precision Neuroscience has 1 robot model on the DEPLOY registry: Precision Layer 7 Cortical Interface (Precision Neuroscience builds physical robots).

Is Precision Neuroscience publicly traded?

No. Precision Neuroscience is privately held and not publicly traded, per the DEPLOY registry.

Who competes with Precision Neuroscience?

On the DEPLOY registry, peer companies to Precision Neuroscience building in the same form factors include Google, Samsung Electronics, Butterfly Network, Abbott.

Who is the CEO of Precision Neuroscience?

Michael Mager is the ceo of Precision Neuroscience, per the DEPLOY registry.

How can I invest in Precision Neuroscience?

Precision Neuroscience is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $120M in disclosed funding.

Where is Precision Neuroscience headquartered?

Precision Neuroscience is headquartered in New York, New York, USA.

How much funding has Precision Neuroscience raised?

Precision Neuroscience has raised approximately $120M in disclosed funding on record in the DEPLOY registry.

Who owns Precision Neuroscience?

Precision Neuroscience is privately held and venture-backed ($120M raised); ownership sits with its founders and private investors.

Where does Precision Neuroscience operate robots?

Precision Neuroscience operates 2 verified deployments, including at United States (multiple hotel chains), Germany, Europe.

How many robots has Precision Neuroscience deployed?

DEPLOY has 2 verified Precision Neuroscience deployments on record at sites including United States (multiple hotel chains), Germany, Europe. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

Is Precision Neuroscience a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Precision Neuroscience ranks in roughly the top 23% of companies tracked by the registry.

When was Precision Neuroscience founded?

Precision Neuroscience was founded in 2021.

Is Precision Neuroscience safe?

Precision Neuroscience has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.